Ambu (AMBU B) Panoramica del titolo
Ambu A/S, società di tecnologia medica, sviluppa, produce e vende dispositivi medici a ospedali, cliniche e servizi di soccorso in tutto il mondo. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 2/6 |
| Crescita futura | 4/6 |
| Prestazioni passate | 5/6 |
| Salute finanziaria | 6/6 |
| Dividendi | 0/6 |
Premi
Analisi del rischio
AMBU B ha superato i nostri controlli di rischio.
AMBU B Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Ambu A/S
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | DKK 67.85 |
| Massimo di 52 settimane | DKK 111.80 |
| Minimo di 52 settimane | DKK 56.25 |
| Beta | 1.36 |
| Variazione di 1 mese | 5.36% |
| Variazione a 3 mesi | 5.44% |
| Variazione di 1 anno | -30.34% |
| Variazione a 3 anni | -33.15% |
| Variazione a 5 anni | -70.94% |
| Variazione dall'IPO | 3,862.05% |
Notizie e aggiornamenti recenti
Aggiornamento della narrazione • Jul 01
AMBU B: Rising Competition Will Weigh On Future Share Performance
The analyst price target for Ambu has been reduced from DKK 78 to DKK 58, with analysts citing a more cautious near term outlook and rising competition as key reasons for the change. Analyst Commentary Recent commentary on Ambu reflects a more cautious tone, with bearish analysts flagging concerns around the company’s ability to deliver against expectations as competition increases.
Aggiornamento della narrazione • Jun 17
AMBU B: Bearish Downgrade And Stable Assumptions May Support Future Repricing
Analysts have reduced their price target on Ambu shares to DKK 88.8, citing a more cautious stance reflected in recent research, including a downgrade from Danske Bank. This comes even as underlying model inputs such as the discount rate, growth and future P/E assumptions remain broadly unchanged.Aggiornamento della narrazione • Jun 03
AMBU B: Bearish Street Sentiment Will Support Future Upside Repricing
Analysts have reduced their price target on Ambu to DKK 88.8, citing a more cautious stance reflected in recent bearish Street research and downgrades. What's in the News Analysts have adopted a more cautious stance on Ambu, reflected in recent bearish research and rating downgrades from the Street.Aggiornamento della narrazione • May 19
AMBU B: Lower P/E Expectations Will Support Future Upside Repricing
Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.Articolo di analisi • May 09
Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...Recent updates
Aggiornamento della narrazione • Jul 01
AMBU B: Rising Competition Will Weigh On Future Share Performance
The analyst price target for Ambu has been reduced from DKK 78 to DKK 58, with analysts citing a more cautious near term outlook and rising competition as key reasons for the change. Analyst Commentary Recent commentary on Ambu reflects a more cautious tone, with bearish analysts flagging concerns around the company’s ability to deliver against expectations as competition increases.Aggiornamento della narrazione • Jun 17
AMBU B: Bearish Downgrade And Stable Assumptions May Support Future Repricing
Analysts have reduced their price target on Ambu shares to DKK 88.8, citing a more cautious stance reflected in recent research, including a downgrade from Danske Bank. This comes even as underlying model inputs such as the discount rate, growth and future P/E assumptions remain broadly unchanged.Aggiornamento della narrazione • Jun 03
AMBU B: Bearish Street Sentiment Will Support Future Upside Repricing
Analysts have reduced their price target on Ambu to DKK 88.8, citing a more cautious stance reflected in recent bearish Street research and downgrades. What's in the News Analysts have adopted a more cautious stance on Ambu, reflected in recent bearish research and rating downgrades from the Street.Aggiornamento della narrazione • May 19
AMBU B: Lower P/E Expectations Will Support Future Upside Repricing
Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.Articolo di analisi • May 09
Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...
Aggiornamento della narrazione • May 04
AMBU B: Higher Growth And Margins Are Expected To Support Future Upside
Analysts have reduced their price target on Ambu by DKK 12. This reflects updated views on discount rates, expected revenue growth, profit margins and future P/E assumptions.Aggiornamento della narrazione • Apr 20
AMBU B: Reset P/E Assumptions Will Support Future Upside Repricing
Ambu's analyst price target has been reduced by DKK 12 to reflect updated views on its P/E assumptions, revenue growth profile and profitability, with analysts pointing to the recent DKK 12 target cut cited in Street research. Analyst Commentary JPMorgan's DKK 12 reduction in its Ambu price target reflects a reset of P/E expectations and a more cautious stance on the company's revenue growth and profitability profile.Aggiornamento della narrazione • Apr 06
AMBU B: Refined Discount Rate And P/E Expectations Will Support Future Upside
Analysts have lowered their price target on Ambu by DKK 12. This reflects small adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following recent research updates.Aggiornamento della narrazione • Mar 22
AMBU B: Lower P/E Assumptions Will Support Upside If Execution Improves
Analysts have lowered their price target on Ambu by DKK 12 to reflect slightly adjusted assumptions on fair value, discount rate, revenue growth, profit margin, and future P/E following the recent JPMorgan target cut to DKK 12. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as a reset that could leave room for upside if Ambu delivers on its operational targets.Aggiornamento della narrazione • Mar 08
AMBU B: Share Repurchase Mandate And Lowered Fair Value Will Support Upside
Analysts have trimmed their price target on Ambu by DKK 12 to reflect updated assumptions on fair value, discount rates and earnings expectations following recent research commentary. Analyst Commentary Bullish Takeaways Bullish analysts view the revised DKK 12 lower price target as still consistent with a supportive fair value range.Aggiornamento della narrazione • Feb 22
AMBU B: Share Buybacks And Margin Discipline Will Support Future Upside
The analyst price target for Ambu has been trimmed by DKK 1 to DKK 138, as analysts factor in slightly more cautious assumptions on growth, margins and discount rates following recent price target adjustments, such as the DKK 12 cut highlighted by JPMorgan. Analyst Commentary Bullish analysts remain focused on how Ambu can justify its current valuation through consistent execution on its growth plans, even as some price targets, including the DKK 12 adjustment flagged by JPMorgan, are recalibrated.Aggiornamento della narrazione • Feb 08
AMBU B: Higher Risk Premium And Margin Pressure Will Reshape Share Outlook
The analyst price target for Ambu has been reduced from DKK 94.54 to DKK 78.00. This change reflects analysts’ updated assumptions on discount rate, revenue growth, profit margin and future P/E, as highlighted by recent Street research including a DKK 12 target cut.Articolo di analisi • Feb 08
Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...Aggiornamento della narrazione • Jan 25
AMBU B: Share Repurchases And Dividend Policy Will Support Future Upside
Analysts have slightly reduced their price target on Ambu, citing modest revisions to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these changes support a more cautious yet still constructive view on the shares.Aggiornamento della narrazione • Jan 11
AMBU B: Share Buybacks And Dividend Policy Will Support Future Upside
Analysts now set Ambu's price target at €139, down from €147, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E that adjust their valuation framework. What's in the News Ambu A/S is set to be removed from the OMX Copenhagen 20 Index, which may affect how some index and benchmark focused investors view or hold the stock (Key Developments).Articolo di analisi • Jan 03
Ambu A/S' (CPH:AMBU B) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 37.7x Ambu A/S ( CPH:AMBU B ) may be sending very bearish signals at the...Aggiornamento della narrazione • Dec 19
AMBU B: Dividend And Share Buybacks Will Drive Future Upside Potential
Analysts have trimmed their price target for Ambu slightly, lowering fair value by about 1 dollar per share as modestly slower expected revenue growth and profit margins are only partly offset by a slightly higher future P/E multiple and lower discount rate. What's in the News Ambu has launched a new share repurchase program starting December 10, 2025, allowing buybacks of up to 10% of its share capital under a mandate valid until December 13, 2027 (company announcement) The company announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with an ex date of December 4 and record date of December 5, 2025 (company announcement) For fiscal 2025/26, Ambu issued guidance for 10% to 13% organic growth and an EBIT margin of 12% to 14%, or 14% to 16% excluding roughly 2 percentage points of tariff impacts (company guidance) Ambu reaffirmed its 2024/25 financial guidance, maintaining expectations for 12% to 14% organic revenue growth (company guidance) Valuation Changes Fair Value Estimate edged down slightly from DKK 115.59 to DKK 114.79 per share, reflecting a modestly lower fundamental valuation.Articolo di analisi • Dec 12
An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Ambu fair value estimate is kr.130 Ambu's kr.85.60 share price...Aggiornamento della narrazione • Dec 05
AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside
Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples. What's in the News Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).Articolo di analisi • Nov 27
We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now
Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...Aggiornamento della narrazione • Nov 21
AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum
Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.Aggiornamento della narrazione • Nov 06
AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements
Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.Articolo di analisi • Oct 07
Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Articolo di analisi • Aug 27
Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.4% to close at kr.98.20 following the...Articolo di analisi • Aug 11
Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?
CPSE:AMBU B 1 Year Share Price vs Fair Value Explore Ambu's Fair Values from the Community and select yours Key...Articolo di analisi • Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it saw significant share price movement during...Articolo di analisi • May 15
Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye
The stock was sluggish on the back of Ambu A/S' ( CPH:AMBU B ) recent earnings report. We have done some analysis, and...Articolo di analisi • Mar 14
Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Articolo di analisi • Feb 02
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts
Ambu A/S ( CPH:AMBU B ) last week reported its latest quarterly results, which makes it a good time for investors to...Articolo di analisi • Jan 27
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Articolo di analisi • Jan 12
Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%
Ambu A/S ( CPH:AMBU B ) shareholders would be excited to see that the share price has had a great month, posting a 27...Articolo di analisi • Dec 31
Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it received a lot of attention from a substantial...
Nuova narrazione • Dec 16
Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth
Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.Articolo di analisi • Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year
Key Insights Ambu will host its Annual General Meeting on 4th of December CEO Britt Jensen's total compensation...Articolo di analisi • Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality
Ambu A/S ( CPH:AMBU B ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that...Articolo di analisi • Nov 07
Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that Ambu A/S ( CPH:AMBU B ) filed its full-year result this time last week. The early...Articolo di analisi • Sep 02
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
It's been a sad week for Ambu A/S ( CPH:AMBU B ), who've watched their investment drop 10% to kr.128 in the week since...Articolo di analisi • Aug 06
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...Articolo di analisi • Apr 06
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
With a median price-to-sales (or "P/S") ratio of close to 6.1x in the Medical Equipment industry in Denmark, you could...Articolo di analisi • Mar 14
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...Articolo di analisi • Feb 01
Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 2.9% to close at kr.115 following the release...Articolo di analisi • Jan 02
A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price
It's not a stretch to say that Ambu A/S' ( CPH:AMBU B ) price-to-sales (or "P/S") ratio of 5.9x right now seems quite...Articolo di analisi • Oct 31
Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?
Key Insights Ambu's estimated fair value is kr.114 based on 2 Stage Free Cash Flow to Equity Ambu's kr.66.00 share...Rendimenti per gli azionisti
| AMBU B | DK Medical Equipment | DK Mercato | |
|---|---|---|---|
| 7D | 5.7% | 2.4% | 1.0% |
| 1Y | -30.3% | -23.7% | -10.2% |
Ritorno vs Industria: AMBU B ha avuto una performance inferiore rispetto al Danish Medical Equipment che ha registrato un rendimento -23.7 % nell'ultimo anno.
Rendimento vs Mercato: AMBU B ha avuto una performance inferiore al mercato Danish che ha registrato un rendimento -10.2 % nell'ultimo anno.
Volatilità dei prezzi
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 4.8% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in DK Market | 7.9% |
| 10% least volatile stocks in DK Market | 2.4% |
Prezzo delle azioni stabile: AMBU B non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato Danish.
Volatilità nel tempo: La volatilità settimanale ( 5% ) di AMBU B è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1937 | 5,200 | Britt Jensen | www.ambu.com |
Ambu A/S, società di tecnologia medica, sviluppa, produce e vende dispositivi medici a ospedali, cliniche e servizi di soccorso in tutto il mondo. L'azienda offre prodotti per l'anestesia, il monitoraggio dei pazienti e la diagnostica. L'azienda offre anche prodotti per l'endoscopia, come broncoscopi, rinolaringoscopi, duodenoscopi, gastroscopi, cistoscopi e unità di visualizzazione; e prodotti per la neurologia, tra cui elettrodi EEG ed EMG, iniezioni guidate EMG e prodotti per il monitoraggio intraoperatorio.
Ambu A/S Riepilogo dei fondamenti
| AMBU B statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | DKK 17.90b |
| Utili (TTM) | DKK 477.00m |
| Ricavi(TTM) | DKK 6.10b |
37.5x
Rapporto P/E2.9x
Rapporto P/SAMBU B è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| AMBU B Conto economico (TTM) | |
|---|---|
| Ricavi | DKK 6.10b |
| Costo del fatturato | DKK 2.44b |
| Profitto lordo | DKK 3.66b |
| Altre spese | DKK 3.18b |
| Utili | DKK 477.00m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
Aug 26, 2026
| Utile per azione (EPS) | 1.81 |
| Margine lordo | 59.98% |
| Margine di profitto netto | 7.81% |
| Rapporto debito/patrimonio netto | 0.3% |
Come si è comportato AMBU B nel lungo periodo?
Vedi performance storica e confrontoDividendi
0.6%
Rendimento attuale del dividendo23%
Rapporto di remunerazioneAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/07/08 05:43 |
| Prezzo dell'azione a fine giornata | 2026/07/08 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/09/30 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Ambu A/S è coperta da 14 analisti. 8 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| null null | ABG Sundal Collier |
| Michael Healy | Berenberg |
| Susannah Ludwig | Bernstein |